Attached files

file filename
EX-32.1 - EX-32.1 - Teladoc Health, Inc.tdoc-20171231ex3214636c8.htm
EX-31.2 - EX-31.2 - Teladoc Health, Inc.tdoc-20171231ex312ececec.htm
EX-31.1 - EX-31.1 - Teladoc Health, Inc.tdoc-20171231ex311a6422e.htm
EX-23.1 - EX-23.1 - Teladoc Health, Inc.tdoc-20171231ex231f3ad75.htm
EX-21 - EX-21 - Teladoc Health, Inc.tdoc-20171231ex21f6b4854.htm
EX-10.8 - EX-10.8 - Teladoc Health, Inc.tdoc-20171231ex10838ac8a.htm
EX-10.7 - EX-10.7 - Teladoc Health, Inc.tdoc-20171231ex107d79860.htm
EX-10.13 - EX-10.13 - Teladoc Health, Inc.tdoc-20171231ex10135fe6d.htm
EX-10.12 - EX-10.12 - Teladoc Health, Inc.tdoc-20171231ex1012b33cf.htm
10-K - 10-K - Teladoc Health, Inc.tdoc-20171231x10k.htm

Exhibit 32.2

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Teladoc, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Mark Hirschhorn, Executive Vice President, Chief Operating Officer and Chief Financial Officer of the Company, certify, to my knowledge, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1.The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

Date: February 27, 2018

    

 

 

 

 

 

 

 

/s/ MARK HIRSCHHORN

 

 

Mark Hirschhorn

 

 

Executive Vice President

 

 

Chief Operating Officer and Chief Financial Officer